Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Elis Pharmaceuticals is a specialty pharmaceutical company with a significant operational presence in India and global headquarters in the United Arab Emirates. The company focuses on the development, manufacturing, and commercialization of high-quality branded generic products across several therapeutic areas, including urology, oncology, cardiology, and pain management. Its portfolio features established treatments for conditions such as benign prostatic hyperplasia and erectile dysfunction, marketed under proprietary brand names. Elis Pharmaceuticals operates state-of-the-art manufacturing facilities that adhere to international GMP standards, enabling the distribution of affordable healthcare solutions to emerging markets. The company is recognized for its strategic focus on niche therapeutic segments and its commitment to expanding its global footprint through robust supply chain and distribution networks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Elis Pharmaceuticals India.